Literature DB >> 15689409

ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection.

Gloria Bonuccelli1, Federica Sotgia, Philippe G Frank, Terence M Williams, Cecilia J de Almeida, Herbert B Tanowitz, Philipp E Scherer, Kylie A Hotchkiss, Bruce I Terman, Brent Rollman, Abdelkrim Alileche, Jürgen Brojatsch, Michael P Lisanti.   

Abstract

Anthrax is a disease caused by infection with spores from the bacteria Bacillus anthracis. These spores enter the body, where they germinate into bacteria and secrete a tripartite toxin that causes local edema and, in systemic infections, death. Recent studies identified the cellular receptor for anthrax toxin (ATR), a type I membrane protein. ATR is one of the splice variants of the tumor endothelial marker 8 (TEM8) gene. ATR and TEM8 are identical throughout their extracellular and transmembrane sequence, and both proteins function as receptors for the toxin. ATR/TEM8 function and expression have been associated with development of the vascular system and with tumor angiogenesis. TEM8 is selectively upregulated in endothelial cells during blood vessel formation and tumorigenesis. However, selective expression of TEM8 in endothelial cells contradicts the presumably ubiquitous expression of the receptor. To resolve this controversial issue, we evaluated the distribution of ATR/TEM8 in a variety of tissues. For this purpose, we generated and characterized a novel anti-ATR/TEM8 polyclonal antibody. Here, we show that this novel antibody recognizes all three ATR/TEM8 isoforms, which are widely and differentially expressed in various tissue types. We found that ATR/TEM8 expression is not only associated with tumor endothelial cells, as previously described. Indeed, ATR/TEM8 is highly and selectively expressed in the epithelial cells lining those organs that constitute the anthrax toxin's sites of entry, i.e., the lung, the skin, and the intestine. In fact, we show that ATR/TEM8 is highly expressed in the respiratory epithelium of the bronchi of the lung and is particularly abundant in the ciliated epithelial cells coating the bronchi. Furthermore, immunostaining of skin biopsies revealed that ATR/TEM8 is highly expressed in the keratinocytes of the epidermis. Finally, we show that the epithelial cells lining the small intestine strongly express ATR/TEM8 isoforms. This is the first demonstration that the ATR/TEM8 protein is highly expressed in epithelial cells, which represent the primary location for bacterial invasion. These results suggest that the ATR/TEM8 expression pattern that we describe here is highly relevant for understanding the pathogenesis of anthrax infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689409     DOI: 10.1152/ajpcell.00582.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  47 in total

1.  Pathophysiological manifestations in mice exposed to anthrax lethal toxin.

Authors:  Nathan C Culley; David M Pinson; Anuradha Chakrabarty; Matthew S Mayo; Steven M LeVine
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  MyD88-dependent signaling protects against anthrax lethal toxin-induced impairment of intestinal barrier function.

Authors:  Shu Okugawa; Mahtab Moayeri; Michael A Eckhaus; Devorah Crown; Sharmina Miller-Randolph; Shihui Liu; Shizuo Akira; Stephen H Leppla
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 3.  Breaking the wall: targeting of the endothelium by pathogenic bacteria.

Authors:  Emmanuel Lemichez; Marc Lecuit; Xavier Nassif; Sandrine Bourdoulous
Journal:  Nat Rev Microbiol       Date:  2009-12-30       Impact factor: 60.633

4.  Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region.

Authors:  Robert Mabry; Mridula Rani; Robert Geiger; Gene B Hubbard; Ricardo Carrion; Kathleen Brasky; Jean L Patterson; George Georgiou; B L Iverson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Bacillus anthracis Edema Toxin Increases Fractional Free Water and Sodium Reabsorption in an Isolated Perfused Rat Kidney Model.

Authors:  Dharmvir S Jaswal; Xizhong Cui; Parizad Torabi-Parizi; Lernik Ohanjanian; Hannish Sampath-Kumar; Yvonne Fitz; Yan Li; Wanying Xu; Peter Q Eichacker
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

6.  Inhibition of anthrax protective antigen outside and inside the cell.

Authors:  Marina V Backer; Vimal Patel; Brian T Jehning; Kevin P Claffey; Vladimir A Karginov; Joseph M Backer
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Authors:  Crystal L Loving; Taruna Khurana; Manuel Osorio; Gloria M Lee; Vanessa K Kelly; Scott Stibitz; Tod J Merkel
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Both CD4+ and CD8+ T cells respond to antigens fused to anthrax lethal toxin.

Authors:  Christine A Shaw; Michael N Starnbach
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells.

Authors:  Nando Dulal Das; Kyoung Hwa Jung; Young Gyu Chai
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

10.  Lung epithelial injury by B. anthracis lethal toxin is caused by MKK-dependent loss of cytoskeletal integrity.

Authors:  Mandy Lehmann; Deborah Noack; Malcolm Wood; Marta Perego; Ulla G Knaus
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.